ICRA Nepal Assigns BBB- to Time Pharma, Upgrades Bikash Hydropower
Wed, Feb 19, 2025 12:01 PM on Latest, Corporate, Credit Rating,
ICRA Nepal has assigned a [ICRANP-IR] BBB- issuer rating to Time Pharmaceuticals Limited, placing it under close monitoring with adverse impact. This rating indicates a moderate level of financial security but also highlights medium credit risk.
Meanwhile, ICRA Nepal has upgraded the issuer rating of Bikash Hydropower Company Limited from [ICRANP-IR] BB to [ICRANP-IR] BBB-. The rating changes reflect general creditworthiness rather than any specific debt instrument.
